Benign breast disease and breast cancer risk: morphology and beyond

The American Journal of Surgical Pathology
Stuart J Schnitt

Abstract

Evidence from clinical follow-up studies has indicated that there is a relationship between the presence of histologically proven benign breast disease and breast cancer risk and that the level of risk varies according to the histologic category of benign breast disease. In particular, proliferative lesions without atypia are associated with a 1.5- to 2-fold increase in risk, whereas atypical hyperplasias are associated with a fourfold to fivefold increase in breast cancer risk. A number of clinical factors appear to modify the risk associated with these lesions, including the time since biopsy, menopausal status, and family history of breast cancer. Recent studies have begun to evaluate the potential role of biologic, molecular, and genetic markers in assessing breast cancer risk in patients with benign breast disease. Additional information derived from clinicopathologic follow-up studies, epidemiologic studies, and molecular and genetic studies will provide new insights into benign breast disease and breast cancer risk.

References

Dec 1, 1992·The American Journal of Surgical Pathology·S J SchnittD L Page
Mar 1, 1991·The American Journal of Surgical Pathology·J Rosai
Mar 12, 1991·International Journal of Cancer. Journal International Du Cancer·D PalliS Bianchi
Sep 1, 1988·American Journal of Epidemiology·C L CarterP R Taylor
Jan 17, 1985·The New England Journal of Medicine·W D Dupont, D L Page
Jan 17, 1985·The New England Journal of Medicine·R V Hutter
Oct 14, 1982·The New England Journal of Medicine·S M LoveW Silen
Apr 20, 1994·Journal of the National Cancer Institute·J M GuinebretièreG Contesso
Sep 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R MillikanL J Melton
Feb 1, 1995·Human Pathology·M YounesR Laucirica
Nov 1, 1993·Breast Cancer Research and Treatment·D L Page, W D Dupont
Jun 15, 1993·Cancer·C A BodianT G Abernathy
Feb 1, 1996·Cancer·K P SiziopikouS J Schnitt
Jun 1, 1996·Cancer·W D Dupont, W D Plummer
Jan 15, 1998·Journal of the National Cancer Institute·S A KhanP J Numann
Sep 10, 1998·Journal of the National Cancer Institute·T E RohanR A Kandel
Feb 11, 1999·The New England Journal of Medicine·T W JacobsS J Schnitt
Jan 19, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A StarkK Conway
Mar 13, 2001·American Journal of Clinical Pathology·T W JacobsS J Schnitt
Jan 18, 2002·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·David A BiddleJungsil Ro
Mar 27, 2002·The American Journal of Surgical Pathology·A M ShaabanC S Foster
May 1, 2002·Advances in Anatomic Pathology·Savitri Krishnamurthy, Nour Sneige

❮ Previous
Next ❯

Citations

Oct 25, 2006·Breast Cancer Research and Treatment·Yan CuiThomas E Rohan
Sep 13, 2007·Breast Cancer Research and Treatment·Stephanie A Navarro Silvera, Thomas E Rohan
Oct 7, 2008·Breast Cancer Research and Treatment·Maria J WorshamSandra R Wolman
Nov 2, 2011·Breast Cancer Research and Treatment·Tami RubinekIdo Wolf
Jan 20, 2010·Cancer Causes & Control : CCC·Geoffrey C KabatThomas E Rohan
Nov 27, 2008·Journal of Mammary Gland Biology and Neoplasia·Quanri Jin, Francisco J Esteva
Jul 22, 2005·The New England Journal of Medicine·Joann G Elmore, Gerd Gigerenzer
Jul 16, 2010·Journal of Oncology·Thomas E RohanGeoffrey C Kabat
Jul 26, 2011·Pathology Research International·Aejaz NasirTimothy J Yeatman
Feb 27, 2004·The Breast Journal·David L Page
Jul 29, 2006·IEEE Transactions on Information Technology in Biomedicine : a Publication of the IEEE Engineering in Medicine and Biology Society·Susan M MaskeryMichael N Liebman
Oct 24, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Abbas RezaianzadehAbdolrasoul Talei
Jul 9, 2008·Laboratory Investigation; a Journal of Technical Methods and Pathology·Charles E WoodJ Mark Cline
Jun 30, 2010·World Journal of Surgery·Ningju WangHuihong Zhai
Dec 29, 2005·International Journal of Cancer. Journal International Du Cancer·Tone B Aaman VamreUNKNOWN WHO Collaborative Study of Neoplasia and Steroid Contraceptives
Oct 21, 2016·Clinical Obstetrics and Gynecology·Brian Orr, Joseph L Kelley
Jul 16, 2014·PloS One·Mengmeng LvJianhua Zhao
Jun 27, 2019·Climacteric : the Journal of the International Menopause Society·W J GouX H Zhang
Mar 6, 2007·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Erin L AshbeckCharles R Key
Sep 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maria J WorshamSandra R Wolman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Breast Cancer Research and Treatment
Maria J WorshamSandra R Wolman
International Journal of Cancer. Journal International Du Cancer
G S BerkowitzC White
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS
Arturo PradoFrancisco Parada
European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
W DobrośE Olszewski
© 2022 Meta ULC. All rights reserved